Publicacións en colaboración con investigadores/as de Universitat Autònoma de Barcelona (36)

2024

  1. Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment

    Journal of Psychopharmacology

  2. Effectiveness of interventions to improve adherence to antidepressant medication in patients with depressive disorders: a cluster randomized controlled trial

    Frontiers in Public Health, Vol. 12

2023

  1. A systematic review of digital interventions for smoking cessation in patients with serious mental illness

    Psychological Medicine, Vol. 53, Núm. 11, pp. 4856-4868

  2. Guía internacional para una dosificación más segura de la clozapina en adultos mediante el uso de 6 titulaciones personalizadas de dosis basados en la etnicidad, la proteína C reactiva y los niveles de clozapina

    Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, Vol. 30, Núm. 3

  3. Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder

    Revista de Psiquiatria y Salud Mental

2022

  1. 2022: IS IT TIME TO OPEN THE DOORS IN THE ACUTE PSYCHIATRIC HOSPITALISATION?

    Actas Espanolas de Psiquiatria

  2. Awareness of illness moderates self-assessment of psychotic symptoms

    Australian and New Zealand Journal of Psychiatry, Vol. 56, Núm. 10, pp. 1287-1294

  3. Effectiveness of interventions to improve medication adherence in adults with depressive disorders: a meta-analysis

    BMC Psychiatry, Vol. 22, Núm. 1

  4. Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))

    Pharmacopsychiatry

  5. Evaluating maintenance electroconvulsive therapy in Bipolar Disorders: 3-year mirror-image study

    Journal of Affective Disorders, Vol. 298, pp. 58-64

  6. Toward Understanding of Suicidality in a Spanish Clinical Population: Validation of the European Spanish Version of the Interpersonal Needs Questionnaire

    Psychopathology, Vol. 55, Núm. 1, pp. 16-27

2021

  1. Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life

    Frontiers in Psychiatry, Vol. 12

  2. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543

  3. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  4. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

  5. Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique

    European Neuropsychopharmacology, Vol. 47, pp. 112-129

  6. Is alexithymia related to retention and relapses in patients with substance use disorders?: A one year follow-up study

    Addictive Behaviors, Vol. 113

  7. Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients

    Acta Psychiatrica Scandinavica, Vol. 143, Núm. 6, pp. 526-534

  8. Pre-training inter-rater reliability of clinical instruments in an international psychosis research project

    Schizophrenia Research

  9. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients with a First Episode of Psychosis

    Journal of Clinical Psychiatry, Vol. 82, Núm. 6